Cargando…
SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer: Toxicity and quality of life assessment
BACKGROUND: Quality of life (QoL) is one of the most significant issues in prostate cancer treatment decisions. This study aimed to investigate the toxicity of hypofractionated stereotactic radiotherapy (SBRT) and QoL after treatment in localized prostate cancer patients. MATERIALS AND METHODS: A pr...
Autores principales: | Rucinska, Monika, Kieszkowska-Grudny, Anna, Nawrocki, Sergiusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919372/ https://www.ncbi.nlm.nih.gov/pubmed/27221312 http://dx.doi.org/10.1007/s00066-016-0971-2 |
Ejemplares similares
-
Identification of Cognitive Strategies Used by Cancer Patients as a Basis for Psychological Self-Support during Oncological Therapy
por: Osowiecka, Karolina, et al.
Publicado: (2022) -
The Waiting Time of Prostate Cancer Patients in Poland
por: Osowiecka, Karolina, et al.
Publicado: (2019) -
Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016) -
Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012) -
The Impact of the COVID-19 Pandemic on the Number of Cancer Patients and Radiotherapy Procedures in the Warmia and Masuria Voivodeship
por: Kurowicki, Marcin, et al.
Publicado: (2023)